Zhende Medical Co (SHSE:603301) Beneish M-Score: -2.58 (As of Sep. 11, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603301 Zhende Medical Co Ltd SHSE:603301
53 GF Score
Price ¥81.24
GF Value ¥26.63
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Zhende Medical Co Beneish M-Score?

Zhende Medical Co SHSE:603301 -3.46% 53 Beneish M-Score is -2.58 as of Sep. 11, 2026. GuruFocus rates SHSE:603301 with a GF Score™ of 53/100 and a GF Value™ of ¥26.63 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 771 Medical Devices & Instruments companies, Zhende Medical Co ranks better than 51.49% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.58 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Zhende Medical Co's Beneish M-Score or its related term are showing as below:

SHSE:603301' s Beneish M-Score Range Over the Past 10 Years
Min: -3.07   Med: -2.21   Max: 0.43
Current: -2.58

During the past 12 years, the highest Beneish M-Score of Zhende Medical Co was 0.43. The lowest was -3.07. And the median was -2.21.


Zhende Medical Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Zhende Medical Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhende Medical Co Beneish M-Score Chart

Zhende Medical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.70 -2.65 -2.62 -2.04 -2.87

Zhende Medical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.47 -2.76 -2.87 -2.79 -2.58

SHSE:603301 vs ISRG, BDX, RMD: Beneish M-Score Comparison

For the Medical Instruments & Supplies subindustry, Zhende Medical Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhende Medical Co Beneish M-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zhende Medical Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Zhende Medical Co's Beneish M-Score falls into.


SHSE:603301
53GF Score
Zhende Medical Co Ltd SHSE:603301
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhende Medical Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Zhende Medical Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.895+0.528 * 0.98+0.404 * 1.1091+0.892 * 1.0305+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9304+4.679 * -0.017484-0.327 * 0.9823
=-2.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun26) TTM:Last Year (Jun25) TTM:
Total Receivables was ¥823 Mil.
Revenue was 1223.646 + 1000.414 + 1145.341 + 1084.063 = ¥4,453 Mil.
Gross Profit was 423.43 + 345.888 + 388.139 + 362.42 = ¥1,520 Mil.
Total Current Assets was ¥2,905 Mil.
Total Assets was ¥8,342 Mil.
Property, Plant and Equipment(Net PPE) was ¥3,482 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥311 Mil.
Total Current Liabilities was ¥1,751 Mil.
Long-Term Debt & Capital Lease Obligation was ¥412 Mil.
Net Income was 89.331 + 54.448 + 57.631 + 75.422 = ¥277 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ¥0 Mil.
Cash Flow from Operations was 39.144 + 5.753 + 275.85 + 101.931 = ¥423 Mil.
Total Receivables was ¥892 Mil.
Revenue was 1108.632 + 991.565 + 1138.496 + 1082.97 = ¥4,322 Mil.
Gross Profit was 378.179 + 339.888 + 361.512 + 365.748 = ¥1,445 Mil.
Total Current Assets was ¥3,244 Mil.
Total Assets was ¥8,377 Mil.
Property, Plant and Equipment(Net PPE) was ¥3,363 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥324 Mil.
Total Current Liabilities was ¥1,828 Mil.
Long-Term Debt & Capital Lease Obligation was ¥384 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(822.514 / 4453.464) / (891.776 / 4321.663)
=0.184691 / 0.20635
=0.895

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1445.327 / 4321.663) / (1519.877 / 4453.464)
=0.334438 / 0.34128
=0.98

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (2904.636 + 3482.367) / 8341.544) / (1 - (3244.279 + 3363.354) / 8377.462)
=0.234314 / 0.211261
=1.1091

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=4453.464 / 4321.663
=1.0305

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 3363.354)) / (0 / (0 + 3482.367))
=0 / 0
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(311.08 / 4453.464) / (324.471 / 4321.663)
=0.069851 / 0.07508
=0.9304

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((412.294 + 1751.002) / 8341.544) / ((383.657 + 1828.142) / 8377.462)
=0.25934 / 0.264018
=0.9823

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(276.832 - 0 - 422.678) / 8341.544
=-0.017484

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Zhende Medical Co has a M-score of -2.58 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.58 mean?
Zhende Medical Co (SHSE:603301) has a Beneish M-Score of -2.58 as of Sep. 11, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Zhende Medical Co and its competitors. According to the industry distribution chart, Zhende Medical Co ranks #374 out of 771 companies in the Medical Devices & Instruments industry, placing it in the top 48.5%.
Is Zhende Medical Co's Beneish M-Score too high?
Zhende Medical Co's current Beneish M-Score is -2.58. Based on the distribution chart, Zhende Medical Co ranks #374 out of 771 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Zhende Medical Co has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Zhende Medical Co's Beneish M-Score compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Zhende Medical Co ranks #374 out of 771 companies for Beneish M-Score. This puts Zhende Medical Co in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Zhende Medical Co and its competitors. Zhende Medical Co's current Beneish M-Score is -2.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhende Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhende Medical Co (SHSE:603301) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥26.63, compared to a current price of ¥81.24 — trading 205.1% above its estimated fair value. The current Beneish M-Score is -2.58. Zhende Medical Co's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Zhende Medical Co (SHSE:603301), the current Beneish M-Score is -2.58 as of Sep. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhende Medical Co (SHSE:603301) Overvalued in 2026?

Based on GuruFocus' analysis, Zhende Medical Co stock appears to be overvalued. The current stock price of ¥81.24 is trading 205.1% above its estimated GF Value™ of ¥26.63. GuruFocus considers Zhende Medical Co to be Significantly Overvalued.

Key valuation signals for SHSE:603301:

  • Beneish M-Score: -2.58
  • GF Value™: ¥26.63 vs. price of ¥81.24 (205.1% above fair value)
  • GF Score™: 53/100 with 4 warning signs

No single metric tells the full story. See the SHSE:603301 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zhende Medical Co Business Description

Address No. 55 Xiangji Road, Gaobu Street, Yuecheng District, Zhejiang Province, Shaoxing City, CHN, 312035
Zhende Medical Co Ltd operates as a supplier of medical care and protection in China. The company is engaged in the production and sales of medical dressings. Its product categories are basic medical dressings, operating room sensory control, pressure therapy and fixation, stoma and chronic wounds, Isolation protection, and personal protection.
53GF Score

Get the complete analysis for SHSE:603301

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥81.24
Price
¥26.63
GF Value